Keyphrases
Bleomycin
100%
Receptor Targets
100%
Interleukin-2
100%
Soluble interleukin-2 Receptor (sIL-2R)
100%
Chimeric Protein
100%
Lung Injury
100%
Lung
42%
Intratracheal
42%
Lung Fibrosis
42%
Lymphocytes
28%
High Affinity
28%
Intratracheal Instillation
28%
Hydroxyproline
28%
Therapeutic Strategies
14%
Older Generation
14%
Evidence Support
14%
Biochemical Analysis
14%
Intraperitoneal Injection
14%
Treatment Group
14%
Twice Daily
14%
T Cells
14%
Morphological Parameters
14%
Selective Expression
14%
Apoptosis-inducing Activity
14%
Lymphocyte Infiltration
14%
Cell Count
14%
Histomorphological
14%
Profibrotic
14%
Bronchoalveolar Lavage Fluid
14%
Weight of Evidence
14%
Activated Lymphocytes
14%
Bleomycin-induced Lung Injury
14%
Bronchoalveolar Lavage Lymphocytosis
14%
Medicine and Dentistry
Bleomycin
100%
Interleukin 2
100%
Interleukin 2 Receptor
100%
Chimeric Protein
100%
Pulmonary Fibrosis
42%
Lung
42%
Lymphocyte
42%
Intratracheal Drug Administration
28%
Hydroxyproline
28%
Programmed Cell Death
14%
Intraperitoneal Drug Administration
14%
Lymphocytosis
14%
T Lymphocyte
14%
Lymphocytic Infiltration
14%
Cell Count
14%
Lung Lavage
14%
Bronchoalveolar Lavage Fluid
14%
Bleomycin-Induced Lung Injury
14%
Treatment Group
14%
Biochemical Analysis
14%
Pharmacology, Toxicology and Pharmaceutical Science
Interleukin 2
100%
Chimeric Protein
100%
Bleomycin
100%
Interleukin 2 Receptor
100%
Lung Fibrosis
42%
Hydroxyproline
28%
Intraperitoneal Injection
14%
Elimination
14%
Lymphocytic Infiltration
14%
Lymphocytosis
14%
Bleomycin-Induced Lung Injury
14%
Treatment Group
14%